Law Firm Probes Option Care Health Merger Deal for Shareholders
Monteverde & Associates is investigating Option Care Health over a potential merger, raising shareholder rights concerns.
A New York-based securities law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), examining whether the company's shareholders are receiving fair treatment in connection with a potential merger or acquisition transaction, according to a firm announcement.
Monteverde & Associates PC, which identifies itself as a merger-and-acquisition class action practice, is leading the probe. The firm was recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report and says it has previously recovered millions of dollars on behalf of shareholders in similar cases.
Read more Retail Investing Platforms Hit 41M Accounts After Record Quarters →
The investigation centers on whether Option Care Health's board of directors fulfilled its fiduciary duties to shareholders during any sale or merger process. Such inquiries typically scrutinize deal terms, the adequacy of any offered premium, and the completeness of disclosures made to investors before a shareholder vote.
Option Care Health is a publicly traded provider of home and alternate-site infusion services. Shareholders with holdings in the company are being encouraged by the firm to contact attorneys to understand their rights before any transaction is finalized. No lawsuit has been publicly confirmed as filed at this stage.
Investigations of this nature are common when publicly traded companies announce or negotiate significant corporate transactions. They can result in class action lawsuits, additional disclosures to shareholders, or negotiated improvements to deal terms. Continue reading at All Financial Services & Investing.
